Skip to main content
Log in

Adrenergic drugs

  • Published:
Clinical Reviews in Allergy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Innes IR, Nickerson M: Sympathomimetic drugs, in Goodman & Gillman (eds): The Pharmacological Basis of Therapeutics. Philadelphia, Saunders, 1969, p 477

    Google Scholar 

  2. Barger G, Dale HH: Chemical structure and sympathomimetic action of amines. J Physiol 41:19–59, 1910

    PubMed  CAS  Google Scholar 

  3. Aviado DM: Sympathomimetic Drugs. Springfield, IL, Charles C Thomas, 1970, pp 95–156

    Google Scholar 

  4. Ahlquist RP: A study of adrenotropic receptors. Am J Physiol 153:586–600, 1948

    PubMed  CAS  Google Scholar 

  5. Lands AM, Arnold A, McAuliff J, et al: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597–598, 1967

    Article  PubMed  CAS  Google Scholar 

  6. Robison GA, Butcher RW, Sutherland EW: Cyclic AMP. New York, Academic Press, 1971

    Google Scholar 

  7. Lichtenstein LM, Margolis S: Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 151:902–903, 1968

    Article  Google Scholar 

  8. Ahrens RC, Hendeles L, Weinberger M: Clinical pharmacology of drugs used in treatment of asthma, in Yaffe SJ (ed): Pediatric Pharmacology. New York, Grane and Stratton, 1980, pp 233–243

    Google Scholar 

  9. Farmer JB, Coleman RA: A new preparation of the isolated intact trachea of the guinea pig. J Pharm Pharmacol 22:46–50, 1970

    PubMed  CAS  Google Scholar 

  10. Furehgott R: The classification of adrenoreceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory, in Eichler, Farah, Herken, Welch (eds): Handbook of Experimental Pharmacology XXXIII. Heidelberg, Springer-Verlag, 1972, pp 282–289

    Google Scholar 

  11. Jack D, Harris DM, Middleton E Jr: Adrenergic agents, in Middleton E, Reed, Ellis (eds): Allergy: Principles and Practice. St. Louis, C.V. Mosby, 1978, pp 404–407

    Google Scholar 

  12. Jenne JW: The clinical pharmacology of albuterol. J Respir Dis, in press

  13. Weiner N: Norephinephrine, epinephrine and sympathomimetic amines, in Gilman, Goodman, Gilman (eds): The Pharmacological Basis of Therapeutics, 6th Ed. New York, Macmillan

  14. Jack D, Harris DM: Beta-adrenergic agents: Mode of action of beta-stimulants with special reference to their use as bronchodilators, in Middleton, Reed, Ellis (eds): Allergy: Principles and Practice. St. Louis, C.V. Mosby, 1978, pp 407–427.

    Google Scholar 

  15. Svedmyr N, Thiringer G: The effects of salbutamol and isoprenaline on beta-2 receptors in patients with chronic lung disease. Postgrad Med J Suppl 44:44–46, 1971

    Google Scholar 

  16. Minatoya H: Studies on bitolterol, di-p-toluate ester of n-tert-butylarterenol: A new long-acting bronchodilator with reduced cardiovascular effects. J Pharmacol Exp Ther 205:515–527, 1978

    Google Scholar 

  17. Auner BP, Jenne JW: Desensitization of isolated human bronchial smooth muscle to beta receptor agonists. J Allergy Clin Immunol 68:51–57, 1981

    Article  Google Scholar 

  18. Jenne JW, Chick TW, Strickland RD, Wall FJ: Subsensitivity of beta-response during therapy with long acting beta-2 preparations. J Allergy Clin Immunol 59:383–390, 1977

    Article  PubMed  CAS  Google Scholar 

  19. Heavey JE, Tattersfield AE: Beta-adrenergic responsiveness in asthmatic and atopic non-asthmatic subjects. Thorax 34:415, 1979 (Abstract)

    Google Scholar 

  20. Holgate SF, Baldwin CJ, Tattersfield AE: Beta-adrenergic agonist resistance in normal human airways. Lancet 2:375–377, 1977

    Article  PubMed  CAS  Google Scholar 

  21. Walker SR, Evans ME, Richards AJ, Paterson JW: The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 13:861–867, 1972

    PubMed  CAS  Google Scholar 

  22. Shenfield GM, Evans ME, Paterson JW: Absorption of drugs by the lung. Br J Clin Pharmacol 3:583–589, 1976

    CAS  Google Scholar 

  23. Evans ME, Walker SR, Brittain RT, Paterson JW: The metabolism of salbutamol in man. Xenobiotica 3:113–120, 1973

    PubMed  CAS  Google Scholar 

  24. Jack D: Albuterol—Are improved selective ß2-stimulant bronchodilators attainable? J Respir Dis, in press

  25. Kennedy MCS, Simpson WT: Human pharmacological and clinical studies on salbutamol: A specific beta-adrenergic bronchodilator. Br J Dis Chest 63:165–174, 1969

    Article  PubMed  CAS  Google Scholar 

  26. Thiringer G, Svedmyr N: Evaluation of skeletal muscle tremor due to bronchodilator agents. Scand J Respir Dis 56:93–102, 1978

    Google Scholar 

  27. Jenne JE, Ridley DJ, Marcucci RA, Droz WS: Tremor response to terbutaline is proportional to the basal physiological tremor. Am Rev Respir Dis 123:101 (part 2), 1981 (Abstract)

    Google Scholar 

  28. Editorial: Alveolar rapture. Lancet 2:137–138, 1978

    Google Scholar 

  29. Bierman CW, Pierson WE: Hand nebulizers and asthma therapy in children and adolescents. Pediatrics 54:668–669, 1974

    PubMed  CAS  Google Scholar 

  30. Walker SR, Evans ME, Richards AJ, Paterson JW: The fate of (14C) sodium cromoglycate in man. J Pharm Pharmacol 24:525–531, 1972

    PubMed  CAS  Google Scholar 

  31. Newman SP, Pavia D, Clarke SE: Improving the bronchial deposition of pressurized aerosols. Chest 80 (Suppl):909–911, 1981

    PubMed  CAS  Google Scholar 

  32. Newman SP, Pavia D, Clark SW: Kinetics of the inhaled route. J Respir Dis, in press

  33. Ruffin RE, Dolovich MB, Oldenburg FA Jr, Newhouse MT: The preferential deposition of inhaled isoproterenol and propanolol in asthmatic patients. Chest 80 (Suppl):904–907, 1981

    Article  PubMed  CAS  Google Scholar 

  34. Hiller FC, Mazumder MK, Renninger RG, Bone RC: Physical properties of therapeutic aerosols. Chest 80 (Suppl):901–903, 1981

    Article  PubMed  CAS  Google Scholar 

  35. Clarke SW, Newman SP: Differences between pressurized aerosol and stable dust particles. Chest 80 (Suppl):907–909, 1981

    PubMed  CAS  Google Scholar 

  36. Garra BJ, Shapiro GG, Pierson WE, et al: A double-blind evaluation of the use of nebulized metaproterenol and isoproterenol in hospitalized asthmatic children and adolescents. J Allergy Clin Immunol 50:63–68, 1977

    Article  Google Scholar 

  37. Kurland G, Williams J, Lewiston N: Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy for asthma. J Allergy Clin Immunol 63:407, 411, 1979

    Article  PubMed  CAS  Google Scholar 

  38. Lands AM, Groblewski GE, Brown TG: Comparison of the action of isoproterenol and several related compounds on blood pressure, heart and bronchioles. Arch Int Pharmacodyn Ther 161:68, 1966

    PubMed  CAS  Google Scholar 

  39. Lands AM, Brown TG: Sympathomimetic (adrenergic) stimulants, in Burger (ed): Drugs Affecting the Peripheral Nervous System, Medicinal Research Series No. 1. London, Edward Arnold, 1968

    Google Scholar 

  40. Kennedy MCS, Jackson SLO: Oral sympathomimetic amines in treatment of asthma. Br Med J 4:1506, 1963

    Google Scholar 

  41. Choc-Kang YFJ, Simpson WT, Grant IWB: Controlled comparison of the bronchodilator effects of three ß-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J 2:287, 1969

    Google Scholar 

  42. Galant SP, Croncy CE, Duriseti S, Strick L: The effect of metaproterenol in chronic asthmatic children receiving therapeutic doses of theophylline. J Allergy Clin Immunol 61:73–79, 1978

    Article  PubMed  CAS  Google Scholar 

  43. Rachelefsky GS, Katz RM, Mickey MR Jr, Siegel SC: Metaproterenol and theophylline in asthmatic children. Ann Allergy 45:207–212, 1980

    PubMed  CAS  Google Scholar 

  44. Bargman J, Persson H, Wetterlin K: Two new groups of selective stimulants of adrenergic ß-receptors. Experientia 25:899, 1969

    Article  Google Scholar 

  45. Dufano MJ, Glass P: The bronchodilator effects of terbutaline: Route of administration and patterns of responses. Ann Allergy 37:357–366, 1976

    Google Scholar 

  46. Williams SJ, Winner SJ, Clark TJA: Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax 36:629–631, 1981

    PubMed  CAS  Google Scholar 

  47. Weber RW, Petty WE, Nelson HS: Aerosolized terbutaline in asthmatics. J Allergy Clin Immunol 63:115–121, 1979

    Article  Google Scholar 

  48. Shapiro GG, McPhillips JJ, Smith K, Furukawa CT, Pierson WE, Bierman CW: Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm. Pediatrics 67:508–513, 1981

    PubMed  CAS  Google Scholar 

  49. Sly RM, Badier B, Faciane J: Comparison of subcutaneous terbutaline with epinephrine in the treatment of asthma in children. J Allergy Clin Immunol 59:128–135, 1977

    Article  PubMed  CAS  Google Scholar 

  50. Ritchie D, Erben A, McLennan L, Landau LI, Phelan PD: Dose of terbutaline respirator solution in children with asthma. N Z Med J 89:332, 1979

    Google Scholar 

  51. Nayler WG: Some observations on the pharmacological effects of salbutamol, with particular reference to the cardiovascular system. PostgTad Med J 47(Suppl):15, 1971

    Google Scholar 

  52. Kenndey MCS, Simpson WT: Human pharmacological and clinical studies on salbutamol: A specific ß-adrenenergjc bronchodilator. Br J Dis Chest 63:165–174, 1969

    Article  Google Scholar 

  53. Bateman SM, Pidgeon J, Spiro SG, Johnson AJ: The metabolic effects of inhaled salbutamol. Br J Clin Pharmacol 5:127–129, 1978

    PubMed  CAS  Google Scholar 

  54. Lawford P, Jones BJM, Milledge JS: Comparison of intravenous and nebulized salbutamol in initial treatment of severe asthma. Br Med J 1:84, 1978

    PubMed  CAS  Google Scholar 

  55. Walton EH, Cockroft A, Griffiths T, et al: Optimal dose of salbutamol respiratory solutions: Comparison of three doses with plasma levels. Thorax 36:625–628, 1981

    Google Scholar 

  56. Johnson AJ, Spiro SG, Pidgeon J, Bateman S, Clarke SW: Intravenous infusion of salbutamol in severe acute asthma. Br Med J 1:1013–1015, 1978

    Article  PubMed  CAS  Google Scholar 

  57. Murray AB, Hardwick DE, Pirie GE, Fraser BM: The effects of pressurized isoproterenol and salbutamol in asthmatic children. Pediatrics 54:746–756, 1974

    PubMed  CAS  Google Scholar 

  58. Tullar BF, Minatoya H, Lorenz RR: Esters of n-tert-butyl-arterenol. Long-acting new bronchodilators with reduced cardiac effects. J Med Chem 19:834, 1979

    Article  Google Scholar 

  59. Webb DR, Mullarkey MF, Mingo TS: Bitolterol mesylate aerosol in chronic bronchial asthma. J Allergy Clin Immunol 69:115, 1982

    Google Scholar 

  60. Affermeier J, Dreyer AC, Brandt HD, Sternberg S: The ß2-selectivity of various ß-adrenergic drugs. S Afr Med J 46:5–12, 1972

    Google Scholar 

  61. McLeod J, Selman J: A comparison of berotec (T17 1154a) and salbutamol aerosols. N Z Med J 78:209–213, 1973

    PubMed  CAS  Google Scholar 

  62. Himori N, Taira N: Assessment of the selectivity of OPC-20, a new ß2-adrenoceptor stimulant, by the use of the blood perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br J Pharmacol 51:9–17, 1977

    Google Scholar 

  63. Koda A, Yamada T: Anti-allergic actions of procaterol, a new beta2 adrenergic drug. Jpn J Allergol 28:3–17, 1979

    Google Scholar 

  64. Sackner MA, Brown LK, Kim SC: Basis of an improved metered aerosol delivery system. Chest 80 (Suppl):915–918, 1981

    PubMed  CAS  Google Scholar 

  65. Bierman CW: New drugs for asthma: A scientific basis for therapy. Chest 72:689–691, 1977

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bierman, C.W. Adrenergic drugs. Clin Rev Allerg 1, 87–104 (1983). https://doi.org/10.1007/BF02991319

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02991319

Keywords

Navigation